New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
08:22 EDTMDT, BCRC.R. Bard Lutonix balloon has 50% chance for approval at best, says Wells Fargo
After reviewing briefing materials posted to the FDA's website for an upcoming advisory committee meeting, Wells Fargo said it expects a "very tough" panel for C.R. Bard's (BCR) Lutonix drug-coated balloon and puts the chance of approval for the product at 50% "at best." Additionally, the firm does not think Bard's data is competitive with stents, which are the standard of care, or with data on Medtronic's (MDT) competing balloon.
News For BCR;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 11, 2014
09:05 EDTMDTMedtronic receives FDA approval for Attain Performa LV quadripolar leads
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use